Ziekenhuis Oost-Limburg - Campus Sint-Jan
About Ziekenhuis Oost-Limburg - Campus Sint-Jan
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Elixir Medical Corporation
3
Eidos Therapeutics, a BridgeBio company
2
Flanders Medical Research Program
2
Hoffmann-La Roche
2
Medtronic Cardiac Rhythm and Heart Failure
2
Medtronic Endovascular
2
Pfizer
2
Spectranetics Corporation
2
Amgen
1
Atrium Medical Corporation
1
Clinical Trials at Ziekenhuis Oost-Limburg - Campus Sint-Jan
During the past decade, Ziekenhuis Oost-Limburg - Campus Sint-Jan conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 15 clinical trials were completed, i.e. on
average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty
2007-02-01
2008-06-01
Completed
375
A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia
2008-06-30
2009-12-31
Completed
35
COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1)
2008-06-01
2012-07-01
Terminated
103
Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions
2008-12-01
2012-12-01
Completed
325
European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)
2008-10-17
2016-10-27
Terminated
409
Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia
2009-09-01
2017-11-30
Completed
358
Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
2009-09-01
2011-09-01
Terminated
12
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ziekenhuis Oost-Limburg - Campus Sint-Jan" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Elixir Medical Corporation" with 3 trials
sponsored, "Eidos Therapeutics, a BridgeBio company" with 2 trials sponsored, "Flanders Medical Research Program" with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include 25 different institutions and
companies that sponsored additional 31 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ziekenhuis Oost-Limburg - Campus Sint-Jan"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "AF Schimetta GMbH" with 1 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Ziekenhuis Oost-Limburg - Campus Sint-Jan
According to Clinical.Site data, the most researched conditions in "Ziekenhuis Oost-Limburg - Campus Sint-Jan" are
"Coronary Artery Disease" (7 trials), "Critical Limb Ischemia" (4 trials), "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Ziekenhuis Oost-Limburg - Campus Sint-Jan" in a lesser frequency.
Clinical Trials Intervention Types at Ziekenhuis Oost-Limburg - Campus Sint-Jan
Most popular intervention types in "Ziekenhuis Oost-Limburg - Campus Sint-Jan" are "Device" (23 trials), "Drug" (15 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Empagliflozin" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Acoramidis (AG10)" (1 trials) and "Angio" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ziekenhuis Oost-Limburg - Campus Sint-Jan
The vast majority of trials in "Ziekenhuis Oost-Limburg - Campus Sint-Jan" are
41 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Ziekenhuis Oost-Limburg - Campus Sint-Jan
Currently, there are NaN active trials in "Ziekenhuis Oost-Limburg - Campus Sint-Jan".
undefined are not yet recruiting,
8 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 23 completed trials in Ziekenhuis Oost-Limburg - Campus Sint-Jan,
1 suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Ziekenhuis Oost-Limburg - Campus Sint-Jan, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 16 trials that are defined as “Not Applicable".